Helen Long
Family · Tupelo, MSNPI 1487261954
Payments from drug & device makers
Across 54 payments — averaging $26.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$241
- AstraZeneca$165
- Boehringer Ingelheim$130
- SK Life Science, Inc.$104
- Livanova USA, Inc.$92
- Biohaven Pharmaceuticals, Inc.$85
- plus $607 from 16 others
What the payments were for
- Speaking & faculty fees$141%
- Food & beverage$1,41299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $241 |
| AstraZeneca(2 entities) | 4 | $165 |
| Boehringer Ingelheim | 3 | $130 |
| SK Life Science, Inc. | 2 | $104 |
| Livanova USA, Inc. | 1 | $92 |
| Biohaven Pharmaceuticals, Inc. | 1 | $85 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
| Novo Nordisk | 2 | $77 |
| UCB, Inc. | 4 | $76 |
| Johnson & Johnson | 3 | $49 |
| Amgen | 3 | $47 |
| Neurocrine Biosciences, Inc. | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| VBI Vaccine (delaware) Inc. | 2 | $32 |
| Pfizer | 1 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $30 |
| Boston Scientific | 1 | $24 |
| Sandoz | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| GSK | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
How this compares
$1,426 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $421 |
| Doxycycline Hyclate | 26 | $240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $226 |
| Methylprednisolone | 32 | $177 |
| Ciprofloxacin Hcl | 17 | $145 |
| Ibuprofen | 15 | $130 |
| Rosuvastatin Calcium | 12 | $128 |
| Atorvastatin Calcium | 18 | $120 |
| Fluconazole | 14 | $118 |
| Azithromycin | 35 | $94 |
| Prednisone | 15 | $77 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $69 |
| Amoxicillin | 27 | $68 |
| Meloxicam | 11 | $61 |
| Lisinopril | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other family in Tupelo
- Jessica EatonTupelo$25K
- Lisa SandersTupelo$16K
- Amanda RobinsonTupelo$15K
- Ashley HensonTupelo$12K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.